Yeliz Demir
- Pharmacology top 0.2%
- Cholinesterase and Neurodegenerative Diseases 54
- Organic Chemistry top 0.5%
- Synthesis and biological activity 18
- Synthesis and Catalytic Reactions 16
- Clinical Biochemistry top 0.5%
- Paraoxonase enzyme and polymorphisms 21
- Toxicology top 0.5%
- Molecular Biology top 2%
- Enzyme function and inhibition 85
- Phenothiazines and Benzothiazines Synthesis and Activities 23
-
- Aldose Reductase and Taurine 31
-
- Biochemical Acid Research Studies 13
- Co-authors
- Şükrü BeydemirCüneyt Türkeşİlhami GülçınParham TaslımıÖmer İrfan KüfrevioğluMustafa ArslanMuhammet Serhat ÖzaslanCüneyt Çağlayan
- Journals
- SHILAP Revista de lepidopterología (2 papers)Molecules (1 paper)Archives of Biochemistry and Biophysics (4 papers)
- Partner nations
- TürkiyeSaudi ArabiaAzerbaijan
In The Last Decade
Yeliz Demir
161 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Pharmacology 2.0k
- Organic Chemistry 2.7k
- Clinical Biochemistry 555
- Toxicology 223
- Molecular Biology 3.7k
Countries citing papers authored by Yeliz Demir
This map shows the geographic impact of Yeliz Demir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeliz Demir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeliz Demir more than expected).
Fields of papers citing papers by Yeliz Demir
This network shows the impact of papers produced by Yeliz Demir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeliz Demir. The network helps show where Yeliz Demir may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yeliz Demir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 15 | |
| 7 | 2025 | 0 | |
| 8 | 2024 | 29 | |
| 9 | 2024 | 18 | |
| 10 | Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studiesbreakdown → | 2024 | 61 |
| 11 | 2024 | 11 | |
| 12 | 2024 | 13 | |
| 13 | 2024 | 4 | |
| 14 | 2024 | 13 | |
| 15 | 2024 | 2 | |
| 16 | 2023 | 19 | |
| 17 | 2021 | 64 | |
| 18 | 2020 | 93 | |
| 19 | 2020 | 58 | |
| 20 | 2014 | 50 |
About Yeliz Demir
Yeliz Demir is a scholar working on Pharmacology, Clinical Biochemistry and Biochemistry, having authored 171 papers that have together received 6.6k indexed citations. Recurring topics across this work include Enzyme function and inhibition (85 papers), Cholinesterase and Neurodegenerative Diseases (54 papers), Aldose Reductase and Taurine (31 papers), Phenothiazines and Benzothiazines Synthesis and Activities (23 papers), Paraoxonase enzyme and polymorphisms (21 papers), Synthesis and biological activity (18 papers), Synthesis and Catalytic Reactions (16 papers) and Biochemical Acid Research Studies (13 papers). The work is most often cited by research in Pharmacology (2.0k citations), Organic Chemistry (2.7k citations) and Clinical Biochemistry (555 citations). Yeliz Demir has collaborated with scholars based in Türkiye, Saudi Arabia and Azerbaijan. Frequent co-authors include Şükrü Beydemir, Cüneyt Türkeş, İlhami Gülçın, Parham Taslımı, Ömer İrfan Küfrevioğlu, Mustafa Arslan, Muhammet Serhat Özaslan, Cüneyt Çağlayan, Fatih Mehmet Kandemır and Mehlika Dilek Altıntop. Their work appears in journals such as SHILAP Revista de lepidopterología, Molecules and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.